Simplex Trading, LLC Editas Medicine, Inc. Transaction History

Simplex Trading, LLC

$2.81 Billion
Q3 2024

A detailed history of Simplex Trading, LLC transactions in Editas Medicine, Inc. stock. As of the latest transaction made, Simplex Trading, LLC holds 51,376 shares of EDIT stock, worth $142,311. This represents 0.01% of its overall portfolio holdings.

Number of Shares

51,376

Previous 70,292 26.91%

Holding current value

$142,311

Previous $328,000 46.65%

% of portfolio

0.01%

Previous 0.01%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	SELL	$3.39 - $5.96 $64,125 - $112,739	-18,916 Reduced 26.91%	51,376 $175,000
Q2 2024 Jul 25, 2024	BUY	$4.67 - $7.28 $199,997 - $311,773	42,826 Added 155.92%	70,292 $328,000
Q1 2024 Apr 25, 2024	BUY	$7.03 - $11.07 $193,085 - $304,048	27,466 New	27,466 $203,000
Q3 2023 Nov 01, 2023	BUY	$6.92 - $9.31 $88,928 - $119,642	12,851 Added 101.54%	25,507 $198,000
Q2 2023 Aug 04, 2023	BUY	$6.36 - $11.47 $46,809 - $84,419	7,360 Added 138.97%	12,656 $104,000
Q1 2023 Apr 27, 2023	BUY	$7.03 - $11.53 $37,230 - $61,062	5,296 New	5,296 $38,000
Q3 2022 Nov 04, 2022	BUY	$12.16 - $19.42 $501,818 - $801,424	41,268 New	41,268 $505,000
Q1 2022 May 02, 2022	SELL	$14.08 - $27.63 $405,447 - $795,633	-28,796 Closed	0 $0
Q4 2021 Feb 23, 2022	SELL	$26.55 - $40.57 $1.78 Million - $2.72 Million	-67,080 Reduced 69.97%	28,796 $764,000
Q3 2021 Oct 28, 2021	BUY	$39.27 - $72.94 $16,611 - $30,853	423 Added 0.44%	95,876 $5.42 Million
Q2 2021 Aug 12, 2021	BUY	$31.29 - $56.64 $525,828 - $951,835	16,805 Added 21.37%	95,453 $5.41 Million
Q1 2021 Apr 26, 2021	BUY	$39.71 - $90.58 $3.12 Million - $7.12 Million	78,648 New	78,648 $0
Q4 2020 Feb 02, 2021	SELL	$27.07 - $84.35 $182,181 - $567,675	-6,730 Closed	0 $0
Q3 2020 Oct 14, 2020	SELL	$28.06 - $37.16 $264,465 - $350,232	-9,425 Reduced 58.34%	6,730 $188,000
Q2 2020 Jul 13, 2020	SELL	$18.5 - $34.34 $1.23 Million - $2.28 Million	-66,429 Reduced 80.44%	16,155 $477,000
Q1 2020 Apr 29, 2020	BUY	$14.88 - $32.78 $885,196 - $1.95 Million	59,489 Added 257.58%	82,584 $1.64 Million
Q4 2019 Feb 05, 2020	BUY	$19.49 - $32.63 $372,843 - $624,211	19,130 Added 482.47%	23,095 $683,000
Q3 2019 Oct 15, 2019	BUY	$22.49 - $26.81 $89,172 - $106,301	3,965 New	3,965 $90,000
Q2 2019 Jul 26, 2019	SELL	$20.48 - $27.76 $351,191 - $476,028	-17,148 Closed	0 $0
Q1 2019 Apr 18, 2019	BUY	$19.43 - $26.41 $301,903 - $410,358	15,538 Added 965.09%	17,148 $0
Q4 2018 Jan 16, 2019	SELL	$18.19 - $31.79 $227,320 - $397,279	-12,497 Reduced 88.59%	1,610 $36,000
Q3 2018 Oct 23, 2018	SELL	$27.65 - $38.39 $297,928 - $413,652	-10,775 Reduced 43.3%	14,107 $448,000
Q2 2018 Jul 30, 2018	SELL	$31.4 - $41.01 $193,989 - $253,359	-6,178 Reduced 19.89%	24,882 $891,000
Q1 2018 Apr 26, 2018	BUY	$29.84 - $44.08 $572,182 - $845,234	19,175 Added 161.34%	31,060 $1.03 Million
Q4 2017 Jan 10, 2018	BUY	$21.89 - $31.34 $39,883 - $57,101	1,822 Added 18.11%	11,885 $365,000
Q3 2017 Oct 25, 2017	BUY	$15.81 - $24.01 $159,096 - $241,612	10,063	10,063 $241,000

Others Institutions Holding EDIT

# of Institutions

245

Shares Held

56.4M

Call Options Held

399K

Put Options Held

394K

View Full List

About Editas Medicine, Inc.

Ticker EDIT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,737,200
Market Cap $190M
Description
Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...

More about EDIT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.

Account

Simplex Trading, LLC Editas Medicine, Inc. Transaction History